UNSPSC 51314352: Dexbrompheniramine/pseudoephedrine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class RE501. This VA Drug Class (RE501) classifies this compound as belonging to the group ANTIHISTAMINE/DECONGESTANT.

UNSPSC 51314352 Dexbrompheniramine/pseudoephedrine is a Commodity code that in recent state and local solicitations covers naloxone, drug deactivation systems, generic multi-source pharmaceuticals, and over-the-counter products distributed through authorized wholesalers and direct-to-manufacturer pharmacy programs. State and local governments procure these items to support community health initiatives, emergency response capabilities, and pharmacy benefit programs serving state employees, local government facilities, and healthcare systems. The issuing bodies include county health departments, state health and human services commissions, and cooperative purchasing alliances serving multiple states and jurisdictions. Seminole County, Florida; the Texas Health and Human Services Commission; and the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) have posted opportunities under or closely aligned with this code in the past four months, indicating active procurement across health agencies and multistate purchasing vehicles.

Recent solicitations show geographic activity in Florida, Texas, and the Upper Midwest. Seminole County, Florida posted an IFB (Solicitation Number IFB60459723LAS) on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, with a response deadline of July 26, 2023. The Texas HHS Commission issued a Request for Information (RFI No. HHS0017013) posted April 3, 2026, to gather vendor capabilities for implementing a Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions program, exploring direct contracting models outside traditional pharmacy benefit managers and wholesalers. The Minnesota Department of Administration's Office of State Procurement issued an RFP through MMCAP (Solicitation Number S1070000015802) posted January 20, 2026, with a response deadline of March 26, 2026, to establish multiple contracts for generic multi-source pharmaceuticals and OTC products distributed across participating state and local government facilities in Minnesota and Oregon through authorized wholesalers including AmerisourceBergen Drug Corporation (Cencora), Cardinal Health, and Morris & Dickson Co., LLC.